February 3, 2022
MALVERN, P.A., February 3, 2022 – YPrime, LLC., a global leader in cloud-based eClinical solutions, announced today it has joined an historic alliance of more than one hundred life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The Decentralized Trials & Research Alliance (DTRA), which launched December 10, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.
“We have always demonstrated our commitment to driving change by taking leadership roles in industry organizations,” says Mark Maietta, President, YPrime. “By joining DTRA, YPrime has an opportunity to share its experience, insights, and ideas that will help chart the future course of clinical trials and accelerate drug development.”
YPrime joins with its peer DTRA Member organizations to provide expertise to identify and address gaps and needs and advance best practices through effective education and communication.
“We are extremely gratified to welcome YPrime to the Decentralized Trials & Research Alliance,” said Amir Kalali, MD, founder of several collaborative life science communities, and co-Chair of DTRA. “By advancing decentralized research we can make the clinical trial process more patient-focused, increase trial efficiency and encourage use of technologies. We are excited by YPrime’s commitment to embracing decentralized trials and to changing the culture that has been the rate limiter to innovation.”
YPrime’s cloud-based technology streamlines clinical trial data collection and management. YPrime’s eCOA and interactive response technology (IRT) platforms introduce greater speed, precision, and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.
The Decentralized Trials & Research Alliance (DTRA) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.